Institutional Ownership Acumen Pharmaceuticals, Inc. (ABOS)
This table provides information about the institutional ownership of Acumen Pharmaceuticals, Inc. (ABOS). We have compiled data on the 81 institutions that hold shares in the stock, with a total of 40.6 Million shares, which have been reported (via 13F filing form) to have a value of $56.9 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ra Capital Management, L.P.
Boston, MA |
Feb 14, 2025 Q4 2024 |
14,932,063
shares
|
$20.6 Million
0.42% of portfolio
|
Q2 2024
New holding
|
|
|
Sands Capital Ventures, LLC
Arlington, VA |
Feb 13, 2025 Q4 2024 |
3,417,075
shares
|
$4.72 Million
2.23% of portfolio
|
Q3 2021
New holding
|
|
|
Franklin Resources Inc
San Mateo, CA |
Feb 12, 2025 Q4 2024 |
3,273,633
shares
|
$4.52 Million
0.0% of portfolio
|
Q4 2024
Reduced 7.76%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,158,661
shares
|
$2.98 Million
0.0% of portfolio
|
Q2 2024
Added 1037.95%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
1,940,771
shares
|
$2.68 Million
0.0% of portfolio
|
Q4 2024
Added 0.35%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,838,916
shares
|
$2.54 Million
0.13% of portfolio
|
Q4 2024
Reduced 20.05%
|
|
|
Knollwood Investment Advisory, LLC
Hunt Valley, MD |
Feb 14, 2025 Q4 2024 |
1,628,510
shares
|
$2.25 Million
0.29% of portfolio
|
Q3 2023
Reduced 2.98%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
1,344,745
shares
|
$1.86 Million
0.0% of portfolio
|
Q4 2024
Reduced 26.71%
|
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
Feb 14, 2025 Q4 2024 |
939,603
shares
|
$1.3 Million
0.01% of portfolio
|
Q1 2024
Added 28.15%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
937,908
shares
|
$1.29 Million
0.0% of portfolio
|
Q4 2024
Added 1387.18%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
870,555
shares
|
$1.2 Million
0.0% of portfolio
|
Q4 2024
Added 0.7%
|
|
|
Laurion Capital Management LP
New York, NY |
Feb 14, 2025 Q4 2024 |
867,046
shares
|
$1.2 Million
0.03% of portfolio
|
Q3 2024
Reduced 26.42%
|
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
715,000
shares
|
$986,699
0.01% of portfolio
|
Q4 2024
Added 12.42%
|
|
|
Pathstone Holdings, LLC
Englewood, NJ |
Feb 14, 2025 Q4 2024 |
606,845
shares
|
$837,446
0.0% of portfolio
|
Q4 2024
Added 17.31%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
525,806
shares
|
$725,612
0.0% of portfolio
|
Q4 2024
Added 1.82%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
499,100
shares
|
$688,758
0.0% of portfolio
|
Q4 2024
Added 6.4%
|
|
|
Pathstone Family Office, LLC
Englewood, NJ |
Nov 08, 2023 Q3 2023 |
478,790
shares
|
$660,730
0.01% of portfolio
|
Q2 2023
Reduced 2.45%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
307,615
shares
|
$424,508
0.0% of portfolio
|
Q4 2024
Reduced 0.4%
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
301,268
shares
|
$415,749
0.0% of portfolio
|
Q4 2024
Reduced 2.66%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
266,216
shares
|
$367,378
0.0% of portfolio
|
Q4 2024
Added 11.29%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Feb 14, 2025 Q4 2024 |
265,769
shares
|
$366,761
0.08% of portfolio
|
Q4 2024
Reduced 0.25%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
257,213
shares
|
$354,953
0.0% of portfolio
|
Q4 2024
Reduced 15.97%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
219,144
shares
|
$302,418
0.0% of portfolio
|
Q4 2024
Added 50.24%
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
148,668
shares
|
$205,161
0.0% of portfolio
|
Q4 2024
Added 7.17%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
141,492
shares
|
$195,258
0.0% of portfolio
|
Q4 2024
Added 521.92%
|